In vitro investigation of anticancer, cell-cycle-inhibitory, and apoptosis-inducing effects of diversin, a natural prenylated coumarin, on bladder carcinoma cells

Zeitschrift fur Naturforschung - Section C Journal of Biosciences

Volumn 69 C, Issue 3-4, 2014, Pages 99-109

  Haghighitalab, Azadeh ^a   Matin, Maryam M ^a   Bahrami, Ahmad Reza ^a   Iranshahi, Mehrdad ^b   Saeinasab, Morvarid ^a   Haghighi, Fereshteh ^a  

^a FERDOWSI UNIVERSITY OF MASHHAD   (Iran)

^b MASHHAD UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Anticancer; Apoptosis; Diversin

Indexed keywords

ANTINEOPLASTIC AGENT; CASPASE 3; COUMARIN DERIVATIVE; DIVERSIN; TERPENE;

APOPTOSIS; ARTICLE; BLADDER TUMOR; CELL CYCLE; CHEMISTRY; COMET ASSAY; DRUG EFFECT; DRUG SCREENING; FLOW CYTOMETRY; HUMAN; IN VITRO STUDY; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

ANTINEOPLASTIC AGENTS; APOPTOSIS; CASPASE 3; CELL CYCLE; CELL LINE, TUMOR; COMET ASSAY; COUMARINS; DRUG SCREENING ASSAYS, ANTITUMOR; FLOW CYTOMETRY; HUMANS; MONOTERPENES; URINARY BLADDER NEOPLASMS;

EID: 84901439987     PISSN: 09395075     EISSN: None     Source Type: Journal    
DOI: 10.5560/ZNC.2013-0006     Document Type: Article

References (53)

1. Alvarez-Delgado C., Reyes-Chilpa R., Estrada-Muniz E., Mendoza-Rodriguez C.-A., Quintero-Ruiz A., Solano J., and Cerbon M.-A. (2009), Coumarin A=AA induces apoptosis-like cell death in HeLa cells mediated by the release of apoptosis-inducing factor. J. Biochem. Mol. Toxicol. 23, 263-272.
2. Askari M., Sahebkar A., and Iranshahi M. (2009), Synthesis and purification of 7-prenyloxycoumarins and herniarin as bioactive natural coumarins. Iran. J. Basic Med. Sci. 12, 63-69.
3. Barthomeuf C., Demeule M., Grassi J., Saidkhodjaev A., and Beliveau R. (2006), Conferone from Ferula schtschurowskiana enhances vinblastine cytotoxicity in MDCK-MDR1 cells by competitively inhibiting P-glycoprotein transport. Planta Med. 72, 634-639.
4. Barthomeuf C., Lim S., Iranshahi M., and Chollet P. (2008), Umbelliprenin from Ferula szowitsiana inhibits the growth of human M4Beu metastatic pigmented malignant melanoma cells through cell-cycle arrest in G1 and induction of caspase-dependent apoptosis. Phytomedicine 15, 103-111.
5. Bradford M.-M. (1976), A rapid and sensitive method for quantitation of microgram quantities of protein utilizing the principle of protein-dye-binding. Anal. Biochem. 72, 248-254.
6. Cepeda V., Fuertes M.-A., Castilla J., Alonso C., Quevedo C., and Pérez J.-M. (2007), Biochemical mechanisms of cisplatin cytotoxicity. Anticancer Agents Med. Chem. 7, 3-18.
7. Chu C.-Y., Tsai Y.-Y., Wang C.-J., Lin W.-L., and Tseng T.-H. (2001), Induction of apoptosis by esculetin in human leukemia cells. Eur. J. Pharmacol. 416, 25-32.
8. Chuang J.-Y., Huang Y.-F., Lu H.-F., Ho H.-C., Yang J.-S., Li T.-M., Chang N.-W., and Chung J.-G. (2007), Coumarin induces cell cycle arrest and apoptosis in human cervical cancer HeLa cells through a mitochondriaand caspase-3-dependent mechanism and NF-kappaB down-regulation. In Vivo 21, 1003-1009.
9. Dighe N.-S., Pattan S.-R., Dengale S.-S., Musmade D.-S., Shelar M., Tambe V., and Hole M.-B. (2010), Synthetic and pharmacological profiles of coumarins: A review. Arch. Appl. Sci. Res. 2, 65-71.
10. Eastman A. (1999), The mechanism of action of cisplatin: from adducts to apoptosis, in cisplatin. In: Chemistry and Biochemistry of Leading Anticancer Drugs (Bernhard L., ed.). Wiley-VCH, Zurich, Switzerland, pp. 111-134.
11. Eguchi Y., Shimizu S., and Tsujimoto Y. (1997), Intracellular ATP levels determine cell death fate by apoptosis or necrosis. Cancer Res. 57, 1835-1840.
12. Fadeel B., Gleiss B., Hogstrand K., Chandra J., Wiedmer T., Sims P.-J., Henter J.-I., Orrenius S., and Samali A. (1999), Phosphatidylserine exposure during apoptosis is a cell-type-specific event and does not correlate with plasma membrane phospholipid scramblase expression. Biochem. Biophys. Res. Commun. 266, 504-511.
13. Finn G., Creaven B., and Egan D. (2003), Modulation of mitogen-activated protein kinases by 6-nitro-7-hydroxycoumarin mediates apoptosis in renal carcinoma cells. Eur. J. Pharmacol. 481, 159-167.
14. Fisher D.-E. (1994), Apoptosis in cancer therapy: crossing the threshold. Cell 78, 539-542.
15. Fraigui O., Lamnaouer D., and Faouzi M.-Y. (2002), Acute toxicity of ferulenol, a 4-hydroxycoumarin isolated from Ferula communis L. Vet. Human. Toxicol. 44, 5-7.
16. Fresco P., Borges F., Diniz C., and Marques M.-P. (2006), New insights on the anticancer properties of dietary polyphenols. Med. Res. Rev. 26, 747-766.
17. Ghobrial I.-M., Witzig T.-E., and Adjei A.-A. (2005), Targeting apoptosis pathways in cancer therapy. CA Cancer J. Clin. 55, 178-194.
18. Gonzalez V.-M., Fuertes M.-A., Alonso C., and Perez J.-M. (2001), Is cisplatin-induced cell death always produced by apoptosis? Mol. Pharmacol. 59, 657-663.
19. Haghighitalab A., Matin M.-M., Bahrami A.-R., Iranshahi M., Haghighi F., and Porsa H. (2014), Enhancement of cisplatin cytotoxicity in combina tion with herniarin in vitro. Drug Chem. Toxicol. doi:10.3109/01480545.2013.834354.
20. Hanslick J.-L., Lau K., Noguchi K.-K., Olney J.-W., Zorumski C.-F., Mennerick S., and Farber N.-B. (2009), Dimethyl sulfoxide (DMSO) produces widespread apoptosis in the developing central nervous system. Neurobiol. Dis. 34, 1-10.
21. Hockenbery D., Nunez G., Milliman C., Schreiber R.-D., and Korsmeyer S.-J. (1990), Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348, 334-336.
22. Iranshahi M., Arfa P., Ramezani M., Jaafari M.-R., Sadeghian H., Bassarello C., Piacente S., and Pizza C. (2007), Sesquiterpene coumarins from Ferula szowitsiana and in vitro antileishmanial activity of 7-prenyloxycoumarins against promastigotes. Phytochemistry 68, 554-561.
23. Iranshahi M., Kalategi F., Rezaee R., Shahverdi A.-R., Ito C., Furukawa H., Tokuda H., and Itoigawa M. (2008), Cancer chemopreventive activity of terpenoid coumarins from Ferula species. Planta Med. 74, 147-150.
24. Iranshahi M., Sahebkar A., Hosseini S.-T., Takasaki M., Konoshima T., and Tokuda H. (2010), Cancer chemopreventive activity of diversin from Ferula diversivittata in vitro and in vivo. Phytomedicine 17, 269-273.
25. Ito C., Itoigawa M., Furukawa H., Tokuda H., Okuda Y., Mukainaka T., Okuda M., and Nishino H. (1999), Anti-tumor-promoting effects of 8-substituted 7-methoxycoumarins on Epstein-Barr virus activation assay. Cancer Lett. 138, 87-92.
26. Jiménez-Orozco F.-A., López-Gonźalez J.-S., Nieto-Rodriguez A., Velasco-Velázquez M.-A., Molina-Guarneros J.-A., Mendoza-Patiño N., Garći{dotless}a-Mondragón M.-J., Elizalde-Galvan P., Léon-Cedeño F., and Mandoki J.-J. (2001), Decrease of cyclin D1 in the human lung adenocarcinoma cell line A-427 by 7-hydroxycoumarin. Lung Cancer 34, 185-194.
27. Kerr J.-F., Wyllie A.-H., and Currie A.-R. (1972), Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 26, 239-257.
28. Kerr J.-F., Winterford C.-M., and Harmon B.-V. (1994), Apoptosis. Its significance in cancer and cancer therapy. Cancer 73, 2013-2026.
29. Kim R., Emi M., and Tanabe K. (2005), Caspase-dependent and independent cell death pathways after DNA damage (Review). Oncol. Rep. 14, 595-599.
30. Kroemer G., Zamzami N., and Susin S.-A. (1997), Mitochondrial control of apoptosis. Immunol. Today 18, 44-51.
31. Lacy A. and O'Kennedy R. (2004), Studies on coumarins and coumarin-related compounds to determine their therapeutic role in the treatment of cancer. Curr. Pharm. Des. 10, 3797-3811.
32. Landowski T.-H., Gleason-Guzman M.-C., and DaltonW.-S. (1997), Selection for drug resistance results in resistance to fas-mediated apoptosis. Blood 89, 1854-1861.
33. Leist M. and Jäättelä M. (2001), Four deaths and a funeral: from caspases to alternative mechanisms. Nat. Rev. Mol. Cell. Biol. 2, 589-598.
34. Leist M., Single B., Castoldi A.-F., Kuhnle S., and Nicotera P. (1997), Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis. J. Exp. Med. 185, 1481-1486.
35. Liu Z., Sun C., Olejniczak E.-T., Meadows R.-P., Betz S.-F., Oost T., Herrmann J., Wu J.-C., and Fesik S.-W. (2000), Structural basis for binding of Smac=DIABLO to the XIAP BIR3 domain. Nature 408, 1004-1008.
36. Lockshin R.-A. and Zakeri Z. (2001), Programmed cell death and apoptosis: origins of the theory. Nat. Rev. Mol. Cell. Biol. 2, 545-550.
37. Lopez-Gonzalez J.-S., Prado-Garcia H., Aguilar-Cazares D., Molina-Guarneros J.-A., Morales-Fuentes J., and Mandoki J.-J. (2004), Apoptosis and cell cycle disturbances induced by coumarin and 7-hydroxycoumarin on human lung carcinoma cell lines. Lung Cancer 43, 275-283.
38. Lowe S.-W. and Lin A.-W. (2000), Apoptosis in cancer. Carcinogenesis 21, 485-495.
39. Madari H., Panda D., Wilson L., and Jacobs R.-S. (2003), Dicoumarol: a unique microtubule stabilizing natural product that is synergistic with taxol. Cancer Res. 63, 1214-1220.
40. Molina-Jimenez M.-F., Sanchez-Reus M.-I., and Benedi J. (2003), Effect of fraxetin and myricetin on rotenoneinduced cytotoxicity in SH-SY5Y cells: comparison with N-acetylcysteine. Eur. J. Pharmacol. 472, 81-87.
41. Morelli M.-P., Cascone T., Troiani T., De Vita F., Orditura M., Laus G., Eckhardt S.-G., Pepe S., Tortora G., and Ciardiello F. (2005), Sequence-dependent antiproliferative effects of cytotoxic drugs and epidermal growth factor receptor inhibitors. Ann. Oncol. 16, iv61-iv68.
42. Mosmann T. (1983), Rapid colourimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. J. Immunol. Methods 65, 55-59.
43. Newman D.-J. and Cragg G.-M. (2007), Natural products as sources of new drugs over the last 25 years. J. Nat. Prod. 70, 461-477.
44. Rassouli F.-B., Matin M.-M., Iranshahi M., and Bahrami A.-R. (2011), Investigating the cytotoxic and apoptosis inducing effects of monoterpenoid stylosin in vitro. Fitoterapia 82, 742-749.
45. Reed J.-C. (2002), Apoptosis-based therapies. Nat. Rev. Drug Discov. 1, 111-121.
46. Saraste A. and Pulkki K. (2000), Morphologic and biochemical hallmarks of apoptosis. Cardiovasc. Res. 45, 528-537.
47. Singh R.-K., Lange T.-S., Kim K.-K., and Brard L. (2011), A coumarin derivative (RKS262) inhibits cell-cycle progression, causes pro-apoptotic signaling and cytotoxicity in ovarian cancer cells. Invest. New Drugs 29, 63-72.
48. Venugopala K.-N., Rashmi V., and Odhav B. (2013), Review on natural coumarin lead compounds for their pharmacological activity. Biomed. Res. Int. doi:10.1155/2013/963248.
49. Vikram R., Sandler C.-M., and Ng C.-S. (2009), Imaging and staging of transitional cell carcinoma: part 1, lower urinary tract. AJR Am. J. Roentgenol. 192, 1481-1487.
50. Willis S.-N. and Adams J.-M. (2005), Life in the balance: how BH3-only proteins induce apoptosis. Curr. Opin. Cell Biol. 17, 617-625.
51. Yin L., Ohno T., Weichselbaum R., Kharbanda S., and Kufe D. (2001), The novel isocoumarin 2-(8-hydroxy-6-methoxy-1-oxo-1H-2-benzopyran-3-yl) propionic acid (NM-3) induces lethality of human carcinoma cells by generation of reactive oxygen species. Mol. Cancer Ther. 1, 43-48.
52. Zapata J.-M., Pawlowski K., Haas E., Ware C.-F., Godzik A., and Reed J.-C. (2001), A diverse family of proteins containing tumor necrosis factor receptor-associated factor domains. J. Biol. Chem. 276, 24242-24252.
53. Zhou R., Vander Heiden M.-G., and Rudin C.-M. (2002), Genotoxic exposure is associated with alterations in glucose uptake and metabolism. Cancer Res. 62, 3515-3520.